Acupuncture for Irritable Bowel Syndrome (IBS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00093327|
Recruitment Status : Completed
First Posted : October 8, 2004
Last Update Posted : August 18, 2006
|Condition or disease||Intervention/treatment||Phase|
|Irritable Bowel Syndrome||Procedure: Acupuncture||Phase 2|
IBS is a disorder that affects colon functioning. Although it does not cause permanent harm or lead to more serious conditions, IBS can cause a great deal of discomfort and distress. The effectiveness of acupuncture in treating various conditions has been investigated in numerous studies. However, little is known about acupuncture's efficacy in treating IBS. This study will determine whether acupuncture can alleviate the symptoms of IBS, including pain relief with defecation, changes in stools, and changes in the frequency of bowel movements.
Participants in this study will be randomly assigned to receive bi-weekly sessions of either active or placebo acupuncture or no treatment for 6 weeks. Study visits will occur at study start, Week 3, and Week 6 (study completion). At each study visit, blood collection will occur to measure levels of cortisol, a stress hormone associated with IBS. Participants will also complete questionnaires about their IBS symptoms. Selected participants will be interviewed at each visit, in order to determine whether participants' interpretations and understanding of IBS influences their response to treatment. Any subject who does not receive active acupuncture during the trial is eligible for 6 free acupuncture treatments after the study is over.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||287 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Acupuncture for Irritable Bowel Syndrome (IBS) Trial|
|Study Start Date :||September 2003|
|Study Completion Date :||April 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00093327
|United States, Massachusetts|
|Beth Israel Deaconess Medical Center, General Clinical Research Center|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Ted Kaptchuk, OMD||Beth Israel Deaconess Medical Center|